Results 301 to 310 of about 376,147 (348)
Some of the next articles are maybe not open access.

Amyloid beta.

The international journal of biochemistry & cell biology, 1999
Amyloid beta (A beta) is a 39-43 residue amyloidogenic peptide that is deposited into the extracellular amyloid plaques which characterize an Alzheimer's disease (AD) brain. A beta is derived from the amyloid precursor protein (APP) and undergoes a toxic conformational change (gain of toxic function).
R, Cappai, A R, White
openaire   +1 more source

Amyloid-Eszett (Aß), a false positive of amyloid-beta (Aβ)

Multiple Sclerosis and Related Disorders, 2022
When the Greek letter beta (β) is accidentally confused for the German letter Eszett (ß), and replaced by it, this can lead to some unfortunate consequences in science, academic publishing, and thus the accuracy of the academic record. In this letter, I document the existence - due to this substitution - of a false positive of amyloid-beta (Aβ), namely
openaire   +2 more sources

Beta-amyloid immunisation in Alzheimer’s disease

Neurological Sciences, 2005
Beta-amyloid immunisation in Alzheimer's ...
openaire   +2 more sources

Amyloid-beta aggregation.

Neuro-degenerative diseases, 2007
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the growing population of elderly people. A hallmark of AD is the accumulation of plaques in the brain of AD patients. The plaques predominantly consist of aggregates of amyloid-beta (Abeta), a peptide of 39-42 amino acids generated in vivo by specific, proteolytic cleavage of ...
Verena H, Finder, Rudi, Glockshuber
openaire   +1 more source

Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity.

Brain : a journal of neurology, 2003
The accumulation of beta-amyloid (A beta) in neuritic plaques is thought to be causative for the progression of Alzheimer's disease (AD). Recently, both active immunization and passive administration of A beta antibodies dramatically attenuated amyloid plaque deposition, neuritic dystrophy, astrogliosis and behaviour deficits in transgenic animals.
Yansheng, Du   +9 more
openaire   +1 more source

Amyloid Beta Neurotoxicity

2017
1.
Ho, WL   +6 more
openaire   +1 more source

beta-Amyloid neurotoxicity.

Functional neurology, 1993
beta-amyloid (beta A, 39-43 amino acids) deposition in brain parenchyma and vessel walls is a major pathological feature of Alzheimer's disease (AD). This is associated with degenerative changes of neuronal cell bodies and processes, and neuronal death.
openaire   +1 more source

Interleukin-1 beta dissociates beta-amyloid precursor protein and beta-amyloid peptide secretion.

FEBS letters, 1994
A heightened production of interleukin 1 beta (IL-1 beta) has been reported in microglial-associated amyloid deposits in Alzheimer's disease (AD) brains. These plaques are composed predominantly of beta/A4 peptide derived from beta-amyloid precursor protein (beta APP).
J P, Vasilakos   +6 more
openaire   +1 more source

Home - About - Disclaimer - Privacy